PB1046

· PhaseBio Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PB1046, covering 2022-07-14 to 2022-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF [Phase 2]

See pricing